MetaADEDB 2.0 @ LMMD
Dilazep
(QVZCXCJXTMIDME-UHFFFAOYSA-N)
Structure
SMILES
COc1cc(cc(c1OC)OC)C(=O)OCCCN1CCCN(CC1)CCCOC(=O)c1cc(OC)c(c(c1)OC)OC
Type(s)
Experimental
ATC code(s)
C01DX10
Molecular Formula:
C31H44N2O10
Molecular Weight:
604.688
Log P:
3.4157
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
0
TPSA:
114.46
CAS Number(s):
20153-98-4; 35898-87-4
Synonym(s)
1.
Dilazep
2.
Asta C 4898
3.
Biopropazepan Trimethoxybenzoate
4.
Cormelian
5.
C 4898, Asta
6.
Trimethoxybenzoate, Biopropazepan
External Link(s)
MeSHD004109
PubChem Compound3074
BindingDB50017691
ChEBI92842
CHEMBLCHEMBL126075
DrugBankDB13715
DrugCentral893
IUPHAR/BPS Guide to PHARMACOLOGY4717
KEGGdr:D07843
Therapeutic Target DatabaseD00GUM
ZINC22454221
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedOFFSIDES
2Altered state of consciousnessOFFSIDES
3AlveolitisOFFSIDES
4Ammonia increasedOFFSIDES
5Aspartate aminotransferase decreasedOFFSIDES
6BedriddenOFFSIDES
7Beta 2 microglobulin urine increasedOFFSIDES
8Blood alkaline phosphatase increasedOFFSIDES
9Blood lactate dehydrogenase decreasedOFFSIDES
10Blood urea increasedOFFSIDES
11Blood uric acidOFFSIDES
12Body TemperatureOFFSIDES
13Cold sweatOFFSIDES
14Completed SuicideOFFSIDES
15Concomitant disease aggravatedOFFSIDES
16Conversion disorderOFFSIDES
17CyanosisOFFSIDES
18Dental FistulaOFFSIDES
19Depressed Level of ConsciousnessOFFSIDES
20Diabetes mellitus inadequate controlOFFSIDES
21Disease ProgressionOFFSIDES
22DysgeusiaOFFSIDES
23Educational problemOFFSIDES
24Feeling abnormalOFFSIDES
25GalactorrheaOFFSIDES
26Hepatic InfarctionOFFSIDES
27HypozincaemiaOFFSIDES
28IncontinenceOFFSIDES
29LeukoencephalopathyOFFSIDES
30Lymphocyte stimulation test positiveOFFSIDES
31MyelodysplasiaOFFSIDES
32Nephrosis9824428CTD
33Nephrotic SyndromeOFFSIDES
34Oculomucocutaneous syndromeOFFSIDES
35OliguriaOFFSIDES
36OverdoseOFFSIDES
37Pharmaceutical product complaintOFFSIDES
38Pneumocystis jiroveci pneumoniaOFFSIDES
39ProctitisOFFSIDES
40Productive CoughOFFSIDES
41Pulmonary InfarctionOFFSIDES
42Pulmonary congestionOFFSIDES
43PurulenceOFFSIDES
44Respiratory FailureOFFSIDES
45Sinoatrial BlockOFFSIDES
46Stevens-Johnson SyndromeOFFSIDES
47Sudden onset of sleepOFFSIDES
48Tooth ExtractionOFFSIDES
49Vascular resistance systemic decreasedOFFSIDES
50Vertebral artery occlusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.